A detailed history of Daiwa Securities Group Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 138 shares of IMCR stock, worth $3,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138
Previous 138 -0.0%
Holding current value
$3,899
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$42.85 - $69.5 $1,456 - $2,363
34 Added 32.69%
138 $9,000
Q4 2022

Feb 06, 2023

BUY
$45.51 - $65.08 $4,733 - $6,768
104 New
104 $6,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.